Search - tctmd.com

Displaying 1 - 20 of 37

Sort: Relevancy | Date

Presentation ESC 2024

Continuation versus Interruption of Oral Anticoagulation during TAVI

Presenter: Dirk-Jan van Ginkel

August 31, 2024

Presentation EuroPCR 2024

Impact of valve type and anaesthesia strategy for TAVI – 5-year results of the SOLVE-TAVI trial

Presenter: Hans-Josef Feistritzer

May 14, 2024

Presentation Miami Valves 2024

New Cerebral Protection Devices for TAVR

Presenter: Fábio S. Brito Jr.

February 03, 2024

Presentation TCT 2023

TCT 508: A Meta-Analysis on the Obesity Paradox in Patients Undergoing Transcatheter Aortic Valve Replacement

Presenter: Nathan Matzko

October 26, 2023

Presentation Interventional Complications 2022

TAVR and Unexplained Hypotension: An Algorithmic Approach

Presenter: Frederick Welt

July 15, 2022

Presentation TCT 2020

TCT ID 6: Ischemic Stroke With Cerebral Protection System During Transcatheter Aortic Valve Replacement

Presenter: Michael Megaly

October 15, 2020

Presentation TCT 2020

TCT 227: The Role of Neighborhood Disadvantage in Predicting Mortality in Patients After Transcatheter Aortic Valve Replacement

Presenter: Jesse Goitia

October 14, 2020

Presentation

Diastolic BP and Heart Rate Are Associated With Mortality in Chronic Aortic Regurgitation

January 08, 2020

Presentation ECHO/IMAGING 2019

Echocardiographic Approach to the CHD: Evaluating the Unoperated Adult

Presenter: William R. Miranda

March 24, 2019

Presentation

TAVR in Oncology Patients With Severe AS

January 10, 2019

Presentation TCT 2018

Case #10: An Arch Complication After Aortic Coarctation Stenting

Presenter: Lee N. Benson, Eric Horlick, Zahid Amin, Makram R. Ebeid, Ioannis Iakovou, Michael J. Lim, Mark Osten, Harsimran Sachdeva Singh, Nathan W Taggart

September 22, 2018

Presentation The Structural Heart Disease Summit 2018

Pharmacotherapy Considerations Trials and Practical Clinical Recommendations

Presenter: George D. Dangas

June 21, 2018

Presentation

Predictors and Clinical Outcomes of Next-Day Discharge After Minimalist TAVR

January 16, 2018

Presentation

Death and Dialysis After TAVR:Analysis of STS/ACC TVT Registry

October 17, 2017

Presentation

Association of PVR With 1-Year Outcomes After TAVR With Sapien 3 Valve

September 27, 2017

Presentation ESC 2017

The Viborg Vascular (VIVA) Randomised Screening Trial

Presenter: Jes Lindholt

August 29, 2017

Presentation

Regional Variation in Utilization, In-Hospital Mortality, and Resource Use of TAVR in US

August 22, 2017

Presentation

Initial Experience of Second-Generation Self-Expandable TAVR System (Evolut R)

February 09, 2017

Presentation

Early Clinical Outcomes with Self-Expandable TAVR System (Evolut R) in Severe AS

Presenter: Jeffrey Popma

February 09, 2017

Presentation TVT 2016

TVT 1176: Compassionate Use of a Self-Expanding Aortic Valve Bioprosthesis in Severe Aortic Regurgitation Without Aortic Stenosis or Annular Calcification

Presenter: Mehul Patel, MD

June 17, 2016

Advertisement

Continuation versus Interruption of Oral Anticoagulation during TAVI

Impact of valve type and anaesthesia strategy for TAVI – 5-year results of the SOLVE-TAVI trial

New Cerebral Protection Devices for TAVR

TCT 508: A Meta-Analysis on the Obesity Paradox in Patients Undergoing Transcatheter Aortic Valve Replacement

TAVR and Unexplained Hypotension: An Algorithmic Approach

TCT ID 6: Ischemic Stroke With Cerebral Protection System During Transcatheter Aortic Valve Replacement

TCT 227: The Role of Neighborhood Disadvantage in Predicting Mortality in Patients After Transcatheter Aortic Valve Replacement

Diastolic BP and Heart Rate Are Associated With Mortality in Chronic Aortic Regurgitation

Echocardiographic Approach to the CHD: Evaluating the Unoperated Adult

TAVR in Oncology Patients With Severe AS

Case #10: An Arch Complication After Aortic Coarctation Stenting

Pharmacotherapy Considerations Trials and Practical Clinical Recommendations

Predictors and Clinical Outcomes of Next-Day Discharge After Minimalist TAVR

Death and Dialysis After TAVR:Analysis of STS/ACC TVT Registry

Association of PVR With 1-Year Outcomes After TAVR With Sapien 3 Valve

The Viborg Vascular (VIVA) Randomised Screening Trial

Regional Variation in Utilization, In-Hospital Mortality, and Resource Use of TAVR in US

Initial Experience of Second-Generation Self-Expandable TAVR System (Evolut R)

Early Clinical Outcomes with Self-Expandable TAVR System (Evolut R) in Severe AS

TVT 1176: Compassionate Use of a Self-Expanding Aortic Valve Bioprosthesis in Severe Aortic Regurgitation Without Aortic Stenosis or Annular Calcification

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content